Modeling HCV kinetics under therapy using PK and PD information
- 1 March 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 5 (3) , 321-332
- https://doi.org/10.1517/17425250902787616
Abstract
(2009). Modeling HCV kinetics under therapy using PK and PD information. Expert Opinion on Drug Metabolism & Toxicology: Vol. 5, No. 3, pp. 321-332.Keywords
This publication has 59 references indexed in Scilit:
- Modeling complex decay profiles of hepatitis B virus during antiviral therapy†‡Hepatology, 2008
- Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α‐2bJournal of Viral Hepatitis, 2008
- Modelling hepatitis C virus kinetics during treatment with pegylated interferon α‐2b: errors in the estimation of viral kinetic parametersJournal of Viral Hepatitis, 2007
- Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacyJournal of Theoretical Biology, 2007
- Second hepatitis C replication compartment indicated by viral dynamics during liver transplantationJournal of Hepatology, 2005
- Modelling viral and immune system dynamicsNature Reviews Immunology, 2002
- PegylationClinical Pharmacokinetics, 2001
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and manJournal of Theoretical Biology, 1968